Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
13,306 total articles
Nexxen announced a strategic partnership with Unity to integrate Unity's in-app mobile gaming inventory into Nexxen's DSP platform. This collaboration offers advertisers and agencies seamless access to premium, AI-resilient, non-cookie-dependent mobile video advertising environments, particularly within highly engaged mobile gaming contexts. The pa…
Wix.com Ltd. will participate in a fireside chat at the 2026 Jefferies Software, Internet, and AI Conference, showcasing its vision and strategy, including growth initiatives powered by AI and the recent acquisition of Base44.
Actuate Therapeutics, a clinical-stage biotech firm focused on difficult-to-treat cancers, has appointed Dr. Martin Huber, an industry veteran with extensive oncology drug development experience, to its Board of Directors. Dr. Huber's expertise is expected to enhance Actuate’s leadership as it advances its lead drug candidate, elraglusib, towards r…
Clean Energy Technologies, Inc. announced that its affiliate Vermont Renewable Gas has signed a Memorandum of Understanding with the Vermont Agency of Natural Resources, securing key regulatory approvals and environmental commitments for its 2.2 MW renewable energy facility in Lyndon, Vermont. The agreement sets a clear path forward under stringent…
Duos Edge AI, a subsidiary of Duos Technologies Group (NASDAQ: DUOT), announced an open house event to showcase its newly operational Edge Data Center in Corpus Christi, Texas. This facility offers over 450kW of critical IT capacity to support AI workloads, network infrastructure, and disaster recovery. The deployment advances Duos Edge AI's missio…
NeOnc Technologies, a clinical-stage biotech developing innovative intranasal therapies targeting central nervous system cancers, has seen significant insider buying from CEO Amir Heshmatpour. This buying pattern suggests strong confidence in the upcoming interim Phase 2a trial results for its lead candidate NEO100 addressing aggressive brain tumor…
Ernexa Therapeutics announced preclinical data demonstrating that their lead cell therapy candidate ERNA-101, combined with PD-1 blockade, achieved complete tumor clearance and 100% survival in ovarian cancer mouse models. This novel therapy remodels the tumor microenvironment from immunosuppressive to immune-activated, enhancing the efficacy of ch…
BlockchAIn Digital Infrastructure, a NYSE American-listed company specializing in AI and high-performance computing digital infrastructure, announced its participation in the 16th Annual LD Micro Invitational Conference. The company's CFO and COO will present recent progress, strategic partnerships, operational milestones, and long-term vision to s…
Star Equity Holdings, a diversified holding company trading on Nasdaq as STRR and STRRP, has made a proposal to acquire 100% of GEE Group (NYSE American: JOB) shares at $0.30 per share through a stock-for-stock transaction using its preferred stock. The offer represents a 33% premium over JOB's closing price and aims to reduce public company costs …
ARKO Petroleum Corp. announced its participation in the 23rd Annual Energy Infrastructure CEO & Investor Conference in May 2026, with scheduled 1-on-1 meetings and a live presentation. The company is a leading wholesale fuel distributor in North America, supplying approximately 2 billion gallons annually across various U.S. regions.
Allogene Therapeutics will report its first quarter 2026 financial results and provide a business update on May 13, 2026, followed by a live webcast and conference call. The clinical-stage biotech company focuses on developing allogeneic CAR T cell therapies for cancer and autoimmune diseases.
Veru Inc., a biopharmaceutical company focused on cardiometabolic and inflammatory diseases, will report its fiscal 2026 Q2 financial results on May 13, 2026. The company is conducting a Phase 2b PLATEAU trial evaluating its obesity drug enobosarm in combination with semaglutide, aiming to achieve better quality weight loss by preserving lean mass.…
InflaRx N.V., a biopharmaceutical firm focused on anti-inflammatory therapeutics, announced a $150 million underwritten offering of 75 million ordinary shares at $2.00 per share. The proceeds are intended to support clinical pipeline advancement, working capital, and general corporate purposes. The offering includes participation from several healt…
XPO, Inc., a leading freight transportation provider in North America, has been named a 2026 VETS Indexes 4 Star Employer for the fourth consecutive year. This recognition underscores XPO's dedication to recruiting and supporting veterans and military-connected individuals, fostering long-term civilian careers and leadership development within the …
Global Mofy AI Limited (Nasdaq: GMM) announced that its U.S. subsidiary Eaglepoint AI Inc. was selected for the NVIDIA Inception Program. This inclusion recognizes Eaglepoint AI's strengths in scalable AI training workflows and high-quality data infrastructure services, and supports Global Mofy's expansion into deeper AI infrastructure and model su…
Upexi, Inc., a Solana-focused digital asset treasury and consumer brands company, provided an update on its $50 million authorized share repurchase program announced in November 2025. As of May 5, 2026, the company has repurchased approximately 2.89 million shares, spending around $2 million, leaving over $47 million available for future repurchase…
Blue Gold Limited announced a significant procedural victory in its arbitration against the Republic of Ghana regarding a $1 billion investment dispute. The tribunal rejected Ghana's request to split the case into separate stages, allowing the arbitration to proceed on a single consolidated track, which Blue Gold states will enable a faster and mor…
CRISPR Therapeutics announces its senior management team will present at the upcoming Bank of America Securities 2026 Global Healthcare Conference, highlighting its pioneering gene editing therapies and robust pipeline. The company recently received approval for CASGEVY4, the first CRISPR-based therapy for certain serious blood diseases, and is ad…
FangDD Network Group Ltd., a China-based property technology company listed on NASDAQ, has filed its annual report for the fiscal year ended December 31, 2025, with the U.S. SEC. The report includes audited consolidated financial statements and is available on the company's investor relations website.
Blink Charging Co. (NASDAQ: BLNK) announced a collaboration with Emobi to integrate its extensive EV charging network into Emobi’s roaming and JustPlug ecosystem. This partnership aims to simplify EV charging for drivers by providing unified access across apps and platforms, enabling automated Plug&Charge experiences without hardware upgrades. The …
CDT Equity Inc. announced that its asset AZD5904, a potent inhibitor of human Myeloperoxidase originally licensed from AstraZeneca, has progressed into the global Patent Cooperation Treaty (PCT) phase, broadening its intellectual property protection. The drug has demonstrated a favorable safety profile in Phase 1 trials and shows promise in treatin…
Giftify, Inc. reports significant enhancements in CardCash.com's fraud detection systems resulting in a 56% reduction in fraud-related declines year-over-year for Q1 2026. This improvement has led to over 100,000 customer orders approved with approval rates exceeding 96%, increased transaction efficiency, and stronger platform performance. The comp…
Innventure, Inc., an industrial growth conglomerate listed on NASDAQ under the ticker INV, announced that Ascent Capital Partners has amended its SEC Schedule 13D filing to include a letter expressing strong support for Innventure's leadership and strategic direction. This endorsement underscores investor confidence in Innventure's approach to buil…
Pliant Therapeutics, a clinical-stage biotechnology company focused on integrin-based therapeutics, announced its participation in the RBC Capital Markets Global Healthcare Conference on May 19, 2026. The company's CEO and CFO will discuss their lead drug candidate PLN-101095, currently in Phase 1b trials targeting advanced or metastatic solid tumo…
Weatherford International has been awarded two significant contracts by Constellation Oil Services to provide managed pressure drilling and well intervention services in Brazil's deepwater offshore markets, reinforcing its presence and operational capabilities in the region through 2030.
